Wells David R. 4
4 · ENDRA Life Sciences Inc. · Filed Sep 30, 2019
Insider Transaction Report
Form 4
Wells David R.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2019-09-27$1.18/sh+10,000$11,800→ 20,000 total
Holdings
- 24,786(indirect: By StoryCorp Consulting)
Common Stock